Business EconomyPosted at: Nov 12 2025 12:41AM


Granules Life Sciences gets first U.S. FDA approval for Hyderabad Facility

Hyderabad, Nov 11 (UNI) Granules India Limited, on Tuesday announced that its wholly owned subsidiary, Granules Life Sciences Private Limited (GLS), located here, has received U.S. Food and Drug Administration (FDA) approval for a product that was the subject of a Pre-Approval Inspection (PAI) conducted between July 28 and August 1.
There was one observation during that inspection, and the GLS had submitted its response within the stipulated time.
With this approval, the GLS facility is now deemed approved by the U.S. FDA, marking a major milestone for Granules India as it expands its finished dosage manufacturing capabilities. This is the first FDA approval for the GLS site, the Hyderabad pharma said in a release here.
The company plans to launch the approved product in the U.S. market soon. The same product is already approved and manufactured at Granules’ Gagillapur facility. The new approval will help strengthen market share and support business continuity through multi-site manufacturing.
“We plan on launching the product into the U.S. market soon. It is an already approved product at our Gagillapur facility, but we plan on building market share with this approval,” said Dr. Krishna Prasad Chigurupati, Chairman & Managing Director, Granules India Limited.
“We also have other products filed from this site and expect the U.S. FDA to approve them following necessary audits if required. This marks the first approval from our second Hyderabad facility with finished dosage capabilities,” he added.
UNI KNR SSP
Please log in to get detailed story.
Tags: #Granules Life Sciences gets first U.S. FDA approval for Hyderabad Facility
More News

Dr Reddy's launches Generic Bosutinib Tablets in US market

13 Jun 2026 | 7:01 PM

Hyderabad, June 13 (UNI) Dr Reddy's Laboratories Ltd on Saturday announced the launch of Bosutinib Tablets 400 mg, a generic equivalent of Bosulif, in the United States, marking its entry as the first generic player in the market for the strength and further expanding its oncology portfolio.

see more..

13 Jun 2026 | 3:00 PM

New Delhi, June 12 (UNI): Retail inflation may have remained below the Reserve Bank of India’s medium-term target of 4 per cent in May, but rising fuel costs, increasing imported inflation and concerns over monsoon progress could push price pressures higher in the coming months, according to a report by SBI Research.

see more..

TADKA on JioHotstar crosses 100 million users

13 Jun 2026 | 10:18 AM

Bengaluru, June 13 (UNI) In a major milestone for India’s evolving digital entertainment landscape, TADKA on JioHotstar has surpassed 100 million users, signaling the mainstream rise of premium micro-content as a distinct entertainment category within the country’s streaming ecosystem.

see more..

Chhattisgarh attracts Rs 9,580 Cr investment proposals at Hyderabad Roadshow

12 Jun 2026 | 11:43 PM

Hyderabad, June 12 (UNI) Chhattisgarh attracted investment proposals worth Rs 9,580 crore across high-growth sectors including data centres, semiconductors and GPU infrastructure, solar energy equipment, textiles, cement, pharmaceuticals and dairy at the state's Investors Connect roadshow held here on Friday.

see more..

Alcoholic Beverage Industry urges Telangana Govt to Clear ₹3,700 Cr dues before Enforcing Early Payment Discount Scheme

12 Jun 2026 | 9:41 PM

Hyderabad, June 12 (UNI) Leading alcoholic beverage industry bodies on Friday urged the Telangana Government to clear more than ₹3,700 crore in pending dues before implementing a new early payment discount mechanism for supplies made to the state-run Telangana State Beverages Corporation Limited (TGBCL).

see more..